Investments
3Portfolio Exits
1
Want to inform investors similar to Triginta Capital GmbH about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Triginta Capital GmbH Investments
3 Investments
Triginta Capital GmbH has made 3 investments. Their latest investment was in Neurotech as part of their Series C - II on March 3, 2010.
Triginta Capital GmbH Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/10/2010 | Series C - II | Neurotech | $15M | No | 3i Group, Abenex, AGF Private Equity, Alpha Engineered Composites, Altamir Amboise SCR, Apax Partners, Atlas Venture, AVIDA Equity Partners, Banexi Ventures, Banque de Vizille, Burrill & Company, Excalibur Fund Managers, Fondinvest Capital, Gimv, Industrie Management Holding, Merlin BioSciences, Nexus Medical Partners, Omega Advisors, Omega Funds, Pound Capital, Private Equity Holding AG, Qualium Investissement, Rothschild Gestion, Sofinnova Partners, Sudinnova, SV Health Investors, Triginta Capital, Triginta Capital GmbH, Versant Ventures, and XAnge | |
11/13/2003 | Unattributed VC | |||||
12/14/1998 | Series B |
Date | 3/10/2010 | 11/13/2003 | 12/14/1998 |
|---|---|---|---|
Round | Series C - II | Unattributed VC | Series B |
Company | Neurotech | ||
Amount | $15M | ||
New? | No | ||
Co-Investors | 3i Group, Abenex, AGF Private Equity, Alpha Engineered Composites, Altamir Amboise SCR, Apax Partners, Atlas Venture, AVIDA Equity Partners, Banexi Ventures, Banque de Vizille, Burrill & Company, Excalibur Fund Managers, Fondinvest Capital, Gimv, Industrie Management Holding, Merlin BioSciences, Nexus Medical Partners, Omega Advisors, Omega Funds, Pound Capital, Private Equity Holding AG, Qualium Investissement, Rothschild Gestion, Sofinnova Partners, Sudinnova, SV Health Investors, Triginta Capital, Triginta Capital GmbH, Versant Ventures, and XAnge | ||
Sources |
Triginta Capital GmbH Portfolio Exits
1 Portfolio Exit
Triginta Capital GmbH has 1 portfolio exit. Their latest portfolio exit was Neurotech on November 12, 2012.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.